Can Prometheus Light A Fire Under Lotronex? GI Specialty Firm Will Add Reps

Prometheus Laboratories has lofty expectations for Lotronex (alosetron), the irritable bowel syndrome drug it is acquiring from GlaxoSmithKline

More from Archive

More from Pink Sheet